Autonomix Medical (AMIX) vs IceCure Medical (ICCM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Autonomix Medical is the larger company by market cap ($6.1 million vs $5.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMIX | ICCM |
|---|---|---|
| Share price | $3.13 | $1.13 |
| Market cap | $6.13M | $5.24M |
| 1-day change | -8.21% | -1.74% |
| EPS (TTM) | $-39.67 | $-6.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.55 | $30.30 |
| 52-week low | $2.44 | $1.05 |
| Distance from 52-week high | -90.38% | -96.27% |
| Analyst consensus | none | none |
| Avg. price target upside | +1778.59% | +1906.19% |
| Average volume | 4.50M | 136.91K |
| Shares outstanding | 1.96M | 4.64M |
| Employees | — | 67 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Autonomix Medical
AMIX stock →Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
Healthcare · Medical Devices
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Healthcare · Medical Devices · 67 employees
AMIX vs ICCM FAQ
Which is bigger, Autonomix Medical or IceCure Medical?
Autonomix Medical (AMIX) is larger, with a market capitalization of $6.13M compared with $5.24M for IceCure Medical (ICCM).
Are Autonomix Medical and IceCure Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.